For such an ancient disease, a glimpse of promising new treatments for Chagas disease
Journal Title: Revista Uningá - Year 2021, Vol 58, Issue 1
Abstract
It has been more than 100 years since the discovery of Chagas Disease (CD). However, the repertoire indicated for its treatment is still limited. Thus, this article aims to present a review of the new pharmacological strategies being studied for CD. This literature review, consisting of 68 articles, from 1957 to 2021, was carried out on several scientific platforms. Positive effects from benznidazole have been described in the acute and chronic phases, in addition to its association with itraconazole in the acute phase. Among the cruzain inhibitors, the compound K777 presented trypanocidal effects, although demonstrating major adverse effects, while its analogue WRR-483 demonstrated great beneficial effects in vivo and in vitro. As for the nitroheterocyclics, fexinidazole showed high rates of cure in animal model, in addition to low toxicity. Nifurtimox, in early chronic stages, was able to delay the progression of tissue damage and reduce the parasite load. The compound WC-9, a squalene synthase inhibitor, showed potential inhibition of T. cruzi replication. Regarding aromatic diamidines, many compounds were able to stop the trypanosome, both in vitro and in vivo models. It was concluded that there are favorable findings to improve the treatment of CD. However, the development of effective new drugs does not only depend on their effective action, but also on numerous variables that must be circumvented, such as the reduction of side effects, treatment time and adherence to the current medication of choice, as well as the investment in production and distribution to the population.
Authors and Affiliations
Sabrina Sehn Hilgert, Sofia Comássio de Paula Lima, Sofia Ferreira Salviano, Cristiane Tefé-Silva.
Keywords
Related Articles
- EP ID EP713139
- DOI doi.org/10.46311/2318-0579.58.eUJ4087
- Views 58
- Downloads 0
Ruta graveolens, Pelargonium graveolens and Hibiscus cannabinus as natural inhibitors of growth of Candida albicans
Candidiasis is an infection caused by fungi of the genus Candida, Candida albicans being the species that most causes the disease in Brazil. The Fluconazole is the conventional medicine used as a treatment of these infec...
The influence of anti-vaccine movements on the children's vaccination schedule: a literature review
Vaccination programs, such as the Brazilian National Immunization Program (PNI in Portuguese), are extremely important for the health and development of children, constituting a key element in combating lifelong disease...
Antifungal effect of a metabolite of Pseudomonas aeruginosa LV strain on azole-resistant Candida albicans
Candida albicans remains the most common agent of candidiasis worldwide. This yeast is generally sensitive to most antifungals, however, the emergence of azole-resistant C. albicans has been reported. In addition, this m...
Carbohydrates, saliva and oral health: A literature review
Carbohydrate is the main source of energy and plays important functions for survival, as an energy fuel, in addition to modulating the oxidation of proteins. The relationship between carbohydrates and tooth decay is in t...
Pelvic physiotherapy performance in the treatment of voiding and sexual dysfunctions in prostatectomized patients: integrative review
In recent years there has been a prevalence of prostate cancer in the male population, mainly affecting men over 65 years of age. The main surgical treatment is total radical prostatectomy. As with any other surgery, ris...